Fırat Ökmen

Fırat Ökmen

Auto-generated profile, based on publicly available information

Fırat Ökmen

Buca Seyfi Demirsoy Eğitim ve Araştırma Hastanesi

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2022 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
HEHüseyin Ekici
Hüseyin Ekici
FÖFırat Ökmen
Fırat Ökmen
MIMetehan Imamoglu
Metehan Imamoglu
AİAyşegül Gizem İmamoğlu
Ayşegül Gizem İmamoğlu
AEAhmet Mete Ergenoğlu
Ahmet Mete Ergenoğlu
Fetal arrhythmias complicate 1-2% of all pregnancies. Ultrasound evaluation and Doppler technology are indispensable in both diagnosis and management. Digoxin, sotalol, flecainide and amiodarone are widely accepted antiarrhythmic agents that are frequently. We reviewed the maternal and fetal outcomes in cases with fetal arrhythmia in a tertiary care center in the last decade. Fetal arrhythmias were classified under three main groups: Irregular rhythms, tachyarrhythmia and bradyarrhythmia. Detailed anatomical evaluation and fetal echocardiography were performed in all cases to determine whether a structural cardiac and extracardiac anomaly accompanied fetal arrhythmia and the type of fetal arrhythmia. Digoxin was started primarily as first-line therapy in patients with persistent fetal tachyarrhythmia. In cases, not responding to digoxin, other antiarrhythmic agents (sotalol, flecainide) were combined with treatment without discontinuing digoxin. Fetal arrhythmia was detected in 36 cases during the study period. 50% (n=18/36) of the cases had supraventricular tachycardia, whereas 28% (n=10/36) of them were fetal bradyarrhythmia and 22% (n=8/36) of them were with various irregular rhythms. Transplacental therapy was initiated in 13 patients with persistent supraventricular tachycardia and atrial flutter regardless of the presence of hydrops. The success rate in transplacental therapy was 77% (n=10/13). Successful transplacental therapy was achieved in approximately 80% of cases and delivery could be postponed to advanced gestational weeks, confirming the crucial role of this treatment for the management of tachyarrhythmia.

15 August 2025 in Medicine
Verified
Journal Article
Open access
GUGulsum Uysal
Gulsum Uysal
CACevdet Adıgüzel
Cevdet Adıgüzel
FOFirat Okmen
Firat Okmen
GHGhaith Hejazi
Ghaith Hejazi
The aim of this study was to analyze the inflammatory markers, including C-reactive protein to albumin (ALB) ratios (CAR), and fibrinogen to ALB ratios (FAR) of pregnant women who visited the obstetrics clinic of our hospital and were diagnosed with previable preterm prelabor rupture of membranes (PPROM), defined as delivery between 20 0/7 and 25 6/7 weeks at the border of fetal viability, and to compare the scores with those of the healthy control group. We also aimed to determine the utility of these laboratory scores in women who aborted or continued their pregnancy and live births. Patients aged 18 to 45 diagnosed with previable PPROM between 16 and 22 weeks with singleton live pregnancies were included. Patients with uterine or fetal anomalies, multiple pregnancies, or history of chronic inflammatory disease were excluded. A total of 79 pregnant women were divided into 2 groups: healthy pregnant controls (control, n = 30) and patients diagnosed with previable PPROM (n = 49). 35/49 (71.4%) preferred expectant management. Of these 35 patients 14/35 (40%) had live birth and 21/35 (60%) had abortions. C-reactive protein (23 mg/dl), CAR (0.84), and FAR values were statistically significantly higher, whereas ALB levels (34.2 g/L) were lower in previable PPROM patients than in controls ( P < .001). More importantly, our findings indicated that the FAR at admission (1.4, P < .001) was positively correlated with abortion in previable PPROM among the patients during expectant management. Receiver operating characteristic analysis revealed that the area under the curve for FAR was 0.840 ( P < .001; sensitivity, 76.2%; specificity, 85.7%), and FAR presented the highest predictive value with a 1.18 cut point for abortion in previable PPROM. While the CAR value was significantly higher in patients with PPROM in the patient and control groups, the FAR value was significantly higher in patients who aborted in the PPROM group than in those with live pregnancies. Routine markers that are readily derived in daily clinical practice, such as the FAR, may have clinical significance in evaluating predicting prognosis in previable PPROM.

2 June 2022 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
FOFirat Okmen
Firat Okmen
HEHuseyin Ekici
Huseyin Ekici
EKErdoğan Koca
Erdoğan Koca
VSVeysel Sucu
Veysel Sucu
MOMerih Ogur
Merih Ogur
RNRaziye Narin
Raziye Narin
In this study, we aimed to assess the determining role of foetal fibronectin (FFN) and plasminogen activator inhibitor type (PAI-1) levels in the antenatal prediction of placenta accreta spectrum in cases with risk factors for placenta accreta spectrum. Singleton live pregnancies with placenta previa or low-lying placenta within 32–34 weeks of gestation were included in the study. The cases were divided into two groups after delivery as those with PAS and those with normal placentation. 54 cases diagnosed with placenta previa or low-lying placenta were included in the study. 17 of the cases underwent peripartum hysterectomy due to placenta accreta spectrum. 37 cases with normal placentation underwent caesarean delivery. Foetal fibronectin (p:.03) and PAI-1 (p:.02) levels were determined to be significantly different between cases with placenta accreta spectrum and cases with normal placentation. AUC for foetal FFN was calculated to be 0.69, while the AUC for, PAI-1was 0.66. Results for both FFN and PAI-1 were not found useful enough for the diagnosis of PAS.

14 September 2018 in Ege Tıp Dergisi
Verified
Journal Article
Open access
PDF file
SASabahattin Anıl ARI
Sabahattin Anıl ARI
FÖFırat Ökmen
Fırat Ökmen
IHİsmet Hortu
İsmet Hortu
AAAli Akdemi̇r
Ali Akdemi̇r
AEAhmet Mete Ergenoğlu
Ahmet Mete Ergenoğlu
İniensefali, boynun aşırı hiperekstansiyonu ve çeşitli seviyelerde vertebral defektlerle birlikte görülen nadir ve letal bir anomalidir. Nadiren doğan bebekler ise kısa sürede kaybedilirler. Literatürde çok az sayıda uzun dönem yaşayan iniensefali hastası olgu sunumları şeklinde yer almaktadır. Fetal seyirden dolayı ilk trimesterde tanı alan olgular için gebelik terminasyonu önerilmelidir. Bu yazıda takipleri olmayan ve geç tanı alan bir iniensefali olgusu sunulmaktadır.

30 September 2020 in Ege Tıp Dergisi
Verified
Journal Article
Open access
PDF file
FÖFırat Ökmen
Fırat Ökmen
HEHüseyin Eki̇ci̇
Hüseyin Eki̇ci̇
MIMetehan Imamoglu
Metehan Imamoglu
SASabahattin Anıl ARI
Sabahattin Anıl ARI
SGSabina Garakhanova
Sabina Garakhanova
AYAhmet Özgür Yeni̇el
Ahmet Özgür Yeni̇el
En tr Aim: In this study, we aimed define a new technique to visualize the aortic arch in order to diagnose aortic arch anomalies with a dorsal approach when fetal spine is in anterior position within the uterus. Materials and Methods: 115 patients who were referred to the prenatal screening unit between gestational weeks 20-40 were admitted to the study. 110 patients with normal cardiac findings and 5 fetuses with postnatally confirmed diagnosis of coarctation of aorta were evaluated with the new technique. Results: Aortic arch of 115 fetuses were successfully visualized with the technique defined in detail. Conclusion: The dorsal approach for the visualization of the aortic arch seems as a durable and a convenient technique for the fetal cardiac evaluation, especially in terms of better diagnostic capability for aortic arch pathologies under circumstances where the ventral approach is not feasible Amaç: Bu çalışmada, fetus dorso-anterior pozisyondayken aort kemerinin görüntülenmesi ve anomalilerinin tespiti için yeni bir teknik tanımlamayı amaçladık. Gereç ve Yöntem: 20. ile 40. gebelik haftalarında prenatal değerlendirme birimine yönlendirilen 115 gebe çalışmaya dahil edildi. Normal bulgulara sahip 115 fetus ile doğum sonrası konfirme edilmiş beş aort koarktasyonlu fetus tanımlanan yeni teknik ile değerlendirildi. Bulgular: 115 dorso anterior duruşlu fetusta aort kemeri tanımlanan yeni teknikle başarıyla gösterilmiştir. Sonuç: Aort kemerinin izlenmesinde dorsal yaklaşım, özellikle ventral yaklaşımın mümkün olmadığı durumlarda aort kemerinin patolojileri için daha iyi tanı kabiliyeti ile uygun bir teknik olarak kullanılabilir.

30 April 2023 in Aegean Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
FÖFırat Ökmen
Fırat Ökmen
HEHuseyin Ekici
Huseyin Ekici
EKErdoğan Koca
Erdoğan Koca
OÖOsman Ökmen
Osman Ökmen
HSHicran Acar Sirinoglu
Hicran Acar Sirinoglu
Objective: To identify the factors impacting the decision of declining to have prenatal diagnostic tests and to determine the reasons for declining in cases with high trisomy risk in prenatal screening tests and those who refuse to undergo prenatal diagnostic tests. Materials and methods: Cases with positive test results in first and second trimester aneuploidy screening tests were included in the study. The patients were divided into two groups those who accepted prenatal diagnostic tests (Group 1) and those who refused prenatal diagnostic tests (Group 2). The patients that refused prenatal diagnostic tests were evaluated with a questionnaire to determine the reasons for refusal. Results: 204 cases were included in the study. 44 (21.6%) of these cases wanted to have prenatal diagnostic tests, while 160 (78.4%) refused to have prenatal diagnosis tests. A significant correlation was found between the decision to refuse the prenatal diagnostic test and the mother's educational status level (p=0.035), whereas no significant correlation was found between the personalized risk ratios and the number of abortions in previous pregnancies. Among the reasons for refusal of prenatal diagnosis test, the main reason was determined to be "Termination of pregnancy is not an option". Conclusion: Pregnant women should be offered all options, including not having a prenatal screening test or a prenatal diagnostic test, by providing accurate and understandable information about the purpose and potential outcomes of prenatal screening tests. Hence, pregnant women can be provided with the opportunity to make an informed choice.